FDA Approved: PERPHENAZINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Perphenazine from Actavis Pharma, Inc. (ANDA207582) to support the generic product's availability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PERPHENAZINE (Perphenazine)

Snippet

SUPPL AP for PERPHENAZINE (PERPHENAZINE)